ArticleOncology letters2022

β-catenin inhibitors ICG-001 and pyrvinium sensitize bortezomib-resistant multiple myeloma cells to bortezomib.

Cuicui WuPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.